CLASS III Device recall · Reported 17 Aug 2016 · FDA Enforcement Report

Medivance ArcticGel Neonatal Pad The pad is designed to fit recalled

C.R. Bard is recalling Medivance ArcticGel Neonatal Pad The pad is designed to fit into an incubator and provide, distributed in 13 states. The recall was initiated on 30 Jun 2016 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesLot Numbers NGAN1721, NGAN1765, NGAP1807, NGAP2009, NGZK5402, NGZKY606, NGZKY607, NGZL3822
Quantity recalled64

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2345-2016
FDA event ID
74609
Recalling firm
C.R. Bard, Covington, GA
Classification
Class III
Status
Terminated
Recall initiated
30 Jun 2016
FDA classified
5 Aug 2016
Reported
17 Aug 2016
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

30 Jun 2016Recall initiated by company
5 Aug 2016Classified by FDA+36 days
17 Aug 2016Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

An internal review of an available product found that the Information For Use only contained English and Japanese languages when a CE-marked 23 language version was expected.

Product as listed by the FDA

Medivance ArcticGel Neonatal Pad The pad is designed to fit into an incubator and provide whole body cooling for patients.

Where it was distributed

US Distribution to the states of : CA, FL, GA, IL, IN, MI, MN, MO, NY, OR, PA, TX, WA, and Internationally to Germany, Italy and Switzerland

CaliforniaFloridaGeorgiaIllinoisIndianaMichiganMinnesotaMissouriNew YorkOregonPennsylvaniaTexasWashington

Questions about this recall

Why was it recalled?

An internal review of an available product found that the Information For Use only contained English and Japanese languages when a CE-marked 23 language version was expected.

Which lots are affected?

Lot Numbers NGAN1721, NGAN1765, NGAP1807, NGAP2009, NGZK5402, NGZKY606, NGZKY607, NGZL3822

Where was it sold?

US Distribution to the states of : CA, FL, GA, IL, IN, MI, MN, MO, NY, OR, PA, TX, WA, and Internationally to Germany, Italy and Switzerland

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from C.R. Bard

All 123

Other Other Medical Devices recalls

All 13,778